Somatostatin for Uveitic Cystoid Macular Edema (CME).

Ocul Immunol Inflamm

Ocular Immunology and Uveitis Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA.

Published: December 2005

Purpose: To report the favorable response of bilateral recalcitrant uveitic cystoid macular edema (CME) to treatment with a somatostatin analog.

Methods: Medical ophthalmic history and the results of ophthalmic examinations were recorded. Fluorescein angiography (FA) studies were reviewed.

Results: A 52-year-old white female with intermediate uveitis developed bilateral recalcitrant CME. Treatment with subcutaneous injections of the somatostatin analog octreotide resulted in partial resolution of the CME and improvement of visual acuity.

Conclusions: Somatostatin may play a role in the treatment of CME secondary to uveitis.

Download full-text PDF

Source
http://dx.doi.org/10.1080/09273940691001964DOI Listing

Publication Analysis

Top Keywords

uveitic cystoid
8
cystoid macular
8
macular edema
8
edema cme
8
bilateral recalcitrant
8
cme treatment
8
cme
5
somatostatin
4
somatostatin uveitic
4
cme purpose
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!